Cargando…
Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
BACKGROUND: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of pravastatin, demonstrated a 19% reduction in coronary outcomes (p = 0.006) after a mean of 3.2 years, with no impact on stroke outcomes or all-cause mortality. However, there was a sugges...
Autores principales: | Lloyd, Suzanne M., Stott, David J., de Craen, Anton J. M., Kearney, Patricia M., Sattar, Naveed, Perry, Ivan, Packard, Christopher J., Briggs, Andrew, Marchbank, Laura, Comber, Harry, Jukema, J. Wouter, Westendorp, Rudi G. J., Trompet, Stella, Buckley, Brendan M., Ford, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759378/ https://www.ncbi.nlm.nih.gov/pubmed/24023757 http://dx.doi.org/10.1371/journal.pone.0072642 |
Ejemplares similares
-
Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Poortvliet, Rosalinde K. E., et al.
Publicado: (2012) -
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Freeman, Dilys J, et al.
Publicado: (2011) -
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
por: Ford, Ian, et al.
Publicado: (2002) -
Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk
por: Drewes, Yvonne M, et al.
Publicado: (2014) -
Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses
por: Trompet, Stella, et al.
Publicado: (2011)